Welcome to our dedicated page for Emerson Elec Co SEC filings (Ticker: EMR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Emerson Electric Co. (EMR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, which offer detailed insight into its automation‑focused business and corporate governance. Emerson is incorporated in Missouri and lists its common stock on the New York Stock Exchange under the symbol EMR, as reflected in its current reports on Form 8‑K.
Through its filings, Emerson describes itself as a global automation and industrial technology company with a portfolio that includes intelligent devices, control systems, industrial software and industrial AI. Current reports on Form 8‑K outline key developments such as changes to segment reporting, where the company explains its five segments: Control Systems & Software, Test & Measurement, Sensors, Final Control and Safety & Productivity. These filings detail how segments are grouped into Software & Systems and Intelligent Devices and describe the types of technologies and brands within each segment.
Emerson’s definitive proxy statement on Schedule 14A provides information on its annual meeting, board structure, executive compensation framework and its value creation approach, including a focus on growth, margin expansion, cash generation and returning cash to shareholders. Other 8‑K filings discuss earnings press releases, share repurchase authorizations and performance‑based equity awards for senior executives, giving additional context on capital allocation and incentive design.
Debt‑related filings, such as Form 25 for a specific series of notes, document the removal of particular debt securities from exchange listing without affecting the listing of EMR common stock. On Stock Titan, these filings are updated as they appear in the SEC’s EDGAR system. AI‑powered tools can help summarize lengthy documents like proxy statements and 8‑Ks, highlight segment descriptions, compensation structures and capital return plans, and make it easier to locate information on topics such as segment definitions, governance practices and security listings within Emerson’s disclosure record.
Emerson Electric President & CEO Lance Karsanbhai reported an open-market sale of 5,700 shares of common stock on March 10, 2026, executed through a trust at a weighted average price of $142.3206 per share.
Following the sale, the trust holds 281,393.0331 shares. He also shows 183,172 shares held directly and additional smaller indirect holdings in custodian accounts for his children and in several 401(k) and related retirement plans, indicating a substantial remaining stake.
Emerson Electric Executive Vice President and COO Ram R. Krishnan reported charitable-style moves rather than market trades. On March 9, 2026, he made bona fide gifts totaling 13,360 shares of common stock, including a 6,680-share transfer involving a revocable trust for which he and his spouse serve as co‑trustees. The gifts carry no transaction price, consistent with their classification as bona fide gifts. After these transfers, he holds 53,366 shares directly, 171,139 shares indirectly through a trust, and 2,055.496 shares indirectly via a 401(k) plan, indicating he retains a substantial ownership position in the company.
Emerson Electric Co. entered into a new $2 billion 364-Day Credit Agreement with a bank syndicate led by JPMorgan Chase Bank, N.A., effective February 10, 2026. The unsecured facility, which expires on February 9, 2027, is available in U.S. dollars under various interest rate options.
The credit line is intended for general corporate purposes, including serving as a liquidity back-up for Emerson’s commercial paper program. There are currently no loans or letters of credit outstanding, and the company states it has no present intention to borrow under this or prior similar facilities.
This agreement replaces Emerson’s prior $3 billion 364-day credit facility that had reached its scheduled expiration. Emerson may designate eligible subsidiaries as borrowers, whose obligations would be unconditionally and irrevocably guaranteed by the company.
Emerson Electric director Matthew S. Levatich reported an open-market sale of 1,476 shares of the company’s common stock on February 10, 2026. The shares were sold at a weighted average price of $162.1604 per share, across multiple trades within a narrow price range.
After this transaction, Levatich directly beneficially owns 24,349 shares of Emerson Electric common stock. The filing notes that detailed trade-by-trade pricing within the reported range is available upon request from the company, any security holder, or the SEC staff.
Emerson Electric insider plans to sell shares under Rule 144. A notice was filed for the proposed sale of 22,500 shares of Emerson common stock through Charles Schwab on or about 02/12/2026, with an aggregate market value of $3,332,925.00. Shares outstanding were 562,000,000.
The shares to be sold were acquired via vesting of restricted stock and performance share awards on 11/03/2025 and 02/02/2026 as equity compensation. The seller, Surendralal Lanca Karsanbhai, reported selling 7,263 common shares in the past three months for gross proceeds of $965,979.00 and affirmed knowledge of no undisclosed material adverse information.
Emerson Electric executive Ram R. Krishnan, Executive Vice President and COO, reported a tax-withholding disposition of 5,319 shares of common stock at $159.055 per share on February 9, 2026, to cover required minimum taxes on a vesting stock grant.
Following this transaction, he directly beneficially owned 60,046 shares of Emerson Electric common stock, with additional indirect holdings of 164,459 shares held by a trust and 2,055.496 shares held in a 401(k) plan.
Emerson Electric officer Nicholas J. Piazza, Senior VP & CPO, reported an open-market sale of 6,703 shares of Emerson Electric common stock on February 9, 2026, at a weighted average price of $159.0698 per share. After this transaction, he directly holds 31,664 shares.
The sale was executed in multiple trades within a price range of $159.18 to $159.05. Piazza remains an officer of the company and continues to have a meaningful direct equity stake following the reported sale.
EMR has a Rule 144 notice covering a planned sale of 1,476 shares of common stock through Pershing Advisor Solutions on the NYSE, with an approximate sale date of February 10, 2026 and an aggregate market value of $223,821.00.
The shares were acquired via restricted stock vesting on February 4, 2025 as compensation. The filing notes 562,000,000 shares of this class outstanding, providing context for the relative size of the proposed sale.
Emerson Electric director Mark A. Blinn reported selling Emerson (EMR) common stock. On February 5, 2026, he sold 1,400 shares at a weighted average price of $152.4368, with individual trades ranging from $152.43 to $152.54. The same day, he also sold 1,476 shares at $152.79. After these transactions, he directly owned 7,555 shares of Emerson Electric common stock.
A holder of common stock has filed a Rule 144 notice to sell 6,703 shares. The planned sale has an aggregate market value of $1,073,988.00 and involves common stock listed on the NYSE. The shares are to be sold through Charles Schwab Corp, with an approximate sale date of 02/09/2026.
The shares to be sold were acquired from the issuer as equity compensation, including restricted stock awards and other equity grants made between 11/06/2024 and 11/06/2025. The issuer has 562,000,000 shares outstanding, providing context for the size of this planned sale.